| 发明名称 |
New Therapeutic Agents |
| 摘要 |
A compound of formula (I) or a compound of formula (II) or pharmaceutically acceptable salts thereof, wherein R1-R7 and X are as defined in the description, and the use of these compounds in therapy, in particular in treating cancer or as an inhibitor of the interaction of the MDM2 protein with p53.
|
| 申请公布号 |
US2011224274(A1) |
申请公布日期 |
2011.09.15 |
| 申请号 |
US200913001372 |
申请日期 |
2009.06.25 |
| 申请人 |
GOLDING BERNARD THOMAS;RIEDINGER CHRISTIANE;GRIFFIN ROGER JOHN;HARDCASCTLE IAN ROBERT;VALEUR ERIC;WATSON ANNA FRANCES;NOBLE MARTIN |
发明人 |
GOLDING BERNARD THOMAS;RIEDINGER CHRISTIANE;GRIFFIN ROGER JOHN;HARDCASCTLE IAN ROBERT;VALEUR ERIC;WATSON ANNA FRANCES;NOBLE MARTIN |
| 分类号 |
A61K31/4035;A61K31/403;A61P35/00;C07D209/48 |
主分类号 |
A61K31/4035 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
